{
  "schema_version": "pdp_json_v1",
  "peptide": {
    "canonical_name": "Desmopressin",
    "short_name": "Desmopressin",
    "aliases": [],
    "classification": {
      "category": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "needs_prescription": false,
      "notes": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon."
    },
    "status": {
      "category": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "jurisdiction": "GLOBAL",
      "last_reviewed": "2026-01-20",
      "human_use_note": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon."
    },
    "structure": {
      "sequence_oneletter": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "amino_acid_seq": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "molecular_formula": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "molecular_weight": null,
      "structure_image_url": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon."
    },
    "risk": {
      "current_score": 5,
      "severity": "moderate",
      "likelihood": "possible",
      "evidence_grade": "unknown",
      "developmental_risk": true,
      "unknowns_penalty": true,
      "rationale": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
      "risk_score": 5
    },
    "sections": {
      "overview": [
        {
          "claim_type": "overview",
          "title": "What it is",
          "population_group": "general",
          "confidence": "unknown",
          "evidence_grade": "unknown",
          "text": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "evidence_refs": []
        }
      ],
      "use_cases": [],
      "mechanism": [],
      "human_effects": [],
      "preclinical_effects": [],
      "hypothesized_effects": [],
      "time_dynamics": [],
      "risks": [],
      "contraindications": [],
      "monitoring": [],
      "observed_exposure_ranges": [
        {
          "route": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "unit": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "min": null,
          "max": null,
          "frequency": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "duration": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "population_group": "general",
          "notes": "Descriptive only. Observed in studies; not instructions.",
          "evidence_refs": []
        }
      ],
      "developmental_risk_block": [
        {
          "claim_type": "risk",
          "population_group": "adolescent",
          "confidence": "unknown",
          "evidence_grade": "unknown",
          "text": "Developmental risk is flagged due to limited adolescent data and uncertain long-term effects. Endocrine, growth, neurodevelopmental, and metabolic setpoints may be sensitive to perturbation. This section is descriptive only; uncertainty is explicitly acknowledged.",
          "evidence_refs": []
        }
      ],
      "interaction_summary": [],
      "current_outlook_bullets": [
        "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
        "general recovery and resilience interest (anecdotal)",
        "common biohacker curiosity due to community reports",
        "interest in mechanisms suggested by early evidence",
        "used in goal-based stacking discussions (anecdotal)",
        "exploration in wellness communities despite evidence limits"
      ]
    },
    "evidence": [
      {
        "id": "E1",
        "title": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
        "source_type": "pubmed",
        "source_id": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
        "url": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
        "published_date": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
        "evidence_grade": "unknown",
        "notes": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon."
      }
    ],
    "changelog": [
      {
        "date": "2026-01-20",
        "change_type": "initial_entry",
        "summary": "Initial canonical entry for Desmopressin",
        "detail": "Generated from queue ingestion (Phase 6). Requires human-authored, evidence-bounded content.",
        "evidence_refs": []
      }
    ],
    "meta": {},
    "topics": {
      "primary": [
        "topic_hormonal_endocrine"
      ]
    },
    "slug": "desmopressin"
  },
  "interactions": {
    "drug_classes": [],
    "supplement_classes": [],
    "peptides": []
  },
  "practical": {
    "bottom_line": "Desmopressin (DDAVP) is a prescription drug that changes water balance and can also affect clotting factors in specific conditions. It is not a wellness peptide; the major danger is hyponatremia (dangerously low sodium).",
    "benefits": [
      "clinical use in diabetes insipidus and certain nighttime urination disorders (medical supervision)",
      "clinical use in specific bleeding disorders (von Willebrand/hemophilia A contexts) under supervision",
      "physiology relevance in vasopressin signaling and water balance"
    ],
    "side_effects_common": [
      "headache",
      "nausea",
      "water retention or swelling"
    ],
    "side_effects_serious": [
      "hyponatremia symptoms (confusion, severe headache, vomiting)",
      "seizure or loss of consciousness (emergency)",
      "severe allergic reaction symptoms (hives, facial swelling, trouble breathing)"
    ],
    "who_should_be_cautious": [
      "people with low sodium history, heart failure, or kidney disease",
      "people taking diuretics or medications that affect sodium/water balance",
      "pregnant or breastfeeding individuals",
      "adolescents (prescription-only context; high consequence if misused)"
    ],
    "schema_version": "practical_block_v1"
  }
}
